Locations

With five R&D centers in the United States (New Jersey) and China (Shanghai, Suzhou, Nanjing, and Nantong), WuXi AppTec DMPK provides services including in vivo and in vitro pharmacokinetics studies, metabolite identification, Non-GLP bioanalysis, radiolabeled compound synthesis, and radiolabeled in vivo PK/ADME study.

The United States
Cranbury, NJ
DMPK Capabilities
- In Vitro ADME Study
- In Vivo Rodent PK Study
- Metabolite Identification (in vivo and in vitro, cold and hot)
- Non-GLP Bioanalysis
- Radiolabeled In Vivo PK/ADME Study (QWBA, mass balance, metaboliteidentification, human AME, etc.)
Shanghai, China
DMPK Capabilities
- In Vitro ADME Study
- In Vivo Rodent PK Study
- Metabolite Identification (in vivo and in vitro, cold and hot)
- Non-GLP Bioanalysis
- Radiolabeled Compound Synthesis
Nanjing, China
DMPK Capabilities
- In Vitro ADME Study
- In Vivo Rodent PK Study
- In Vivo Non-rodent (large animal) PK Study
- Metabolite Identification (in vivo and in vitro, cold and hot)
- Non-GLP Bioanalysis
- Radiolabeled In Vivo PK/ADME Study (QWBA, mass balance, metabolite identification, human AME. etc.)
Suzhou, China
DMPK Capabilities
- In Vivo Rodent PK Study
- In Vivo Non-rodent (large animal) PK Study
- Non-GLP Bioanalysis
Nantong, China
DMPK Capabilities
- In Vivo Non-rodent (large animal) PK Study
- Non-GLP Bioanalysis

Stay Connected

Keep up with the latest news and insights.

Email address*

* Please check the filled content
First name*

* Please check the filled content
Last name*

* Please check the filled content
Company*

* Please check the filled content

By clicking submit, you consent to WuXi AppTec DMPK collecting and processing the information you provide for our internal purposes, in accordance with our privacy policy.

* Please agree to the Privacy Policy

Submit

Locations

The United StatesCranbury, NJ

Shanghai, China

Nanjing, China

Suzhou, China

Nantong, China

Stay Connected

The United States
Cranbury, NJ